The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran-Reference-Cited by-同舟云学术

The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran

Published:2024-07-29 Issue:9 Volume:17 Page:643-650
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Amini Abdullah¹,Taherifard Erfan²³^ORCID,Akbari Mohammadreza⁴,Taherifard Ehsan²,Dehdari Ebrahimi Niloofar⁵,Rajabi Mohammad Reza⁵,Zamani Fahimeh⁶,Rekabpour Seyed Javad⁷,Jafaraghaie Razieh⁸,Hassanzadeh Jafar¹,Molavi Vardanjani Hossein³⁹

Affiliation:

1. Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran

2. Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

3. MPH Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4. Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

5. Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

6. Department of Nursing, Kazerun Branch, Islamic Azad University, Kazerun, Iran

7. Department of Hematology and Oncology, Bushehr University of Medical Sciences, Bushehr, Iran

8. Department of Mathematics and Statistics, Shoushtar Branch, Islamic Azad University, Shoushtar, Iran

9. Research Center for Traditional Medicine and History of Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Funder

Shiraz University of Medical Sciences

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2024.2385482

Reference59 articles.

1. Sedrak AK, Kondamudi NP. Sickle Cell Disease (Archived). In: StatPearls [internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan [updated 2023 Aug 28]. https://www.ncbi.nlm.nih.gov/books/NBK482384/

2. Loscalzo J, Fauci A, Kasper D, et al. Harrison’s principles of internal medicine, 21e. New York (NY): McGraw-Hill Education; 2022. p. 633–636, chapter 127.

3. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021

4. CDC’s sickle cell data collection. Data brief: healthcare utilization for Vaso-occlusive episodes by people with sickle cell disease in California and Georgia 2015 National Center on birth defects and developmental disabilities centers for disease control and Prevention. 2015. [cited 2023 Jul 3]. Available from: https://www.cdc.gov/ncbddd/hemoglobinopathies/scdc-voe-data-brief.html

5. Epidemiology and Predictors of all-cause 30-Day readmission in patients with sickle cell crisis